KMB
30
-3
LB
9
-3
XOM
37
-2
PAYX
47
-3
STZ
55
-3
EFX
46
2
VRSK
63
-3
AZO
58
-2
WBA
60
-6
DFS
71
4
NEM
50
2
PNR
72
3
TGNA
53
-3
NI
67
2
L
58
3
LEG
36
5
NKE
42
6
A
41
-3
PVH
62
2
ABT
53
-3
KMB
30
-3
LB
9
-3
XOM
37
-2
PAYX
47
-3
STZ
55
-3
EFX
46
2
VRSK
63
-3
AZO
58
-2
WBA
60
-6
DFS
71
4
NEM
50
2
PNR
72
3
TGNA
53
-3
NI
67
2
L
58
3
LEG
36
5
NKE
42
6
A
41
-3
PVH
62
2
ABT
53
-3
Financhill
Back

NBI Global Real Assets Income ETF Vs. Aligos Therapeutics Industry Stock Comparison

Sell
50

NREA.TO
NBI Global Real Assets Income ETF

Last Price:
22.63
Seasonality Move:
-1.12%
Buy
72

ALGS
Aligos Therapeutics

Last Price:
33.28
Seasonality Move:
10.65%
Sell
50
NBI Global Real Assets Income ETF (NREA.TO) is a Sell

Is NBI Global Real Assets Income ETF a Buy, Sell or Hold?

  • The current NBI Global Real Assets Income ETF [NREA.TO] share price is $22.63. The Score for NREA.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • NREA.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $33.11. The Score for ALGS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NREA.TO Stock Price Chart

What is NBI Global Real Assets Income ETF's stock price today?

  • The NBI Global Real Assets Income ETF share price today is $22.63
    The current trend is moderately bearish and NREA.TO is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $33.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.

NREA.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 43.97 Sell
Chaikin Money Flow: -1471 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.85 Buy
Relative Strength Index (14 RSI): 78.88 Buy
Chaikin Money Flow: -127407 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.12 - 28.52) Buy
Bollinger Bands (100): (7.57 - 20.11) Buy

NREA.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.03 Sell
20-day SMA: 22.98 Sell
50-day SMA: 22.5 Buy
200-day SMA: 20.73 Buy
8-day EMA: 22.98 Sell
20-day EMA: 22.9 Sell
50-day EMA: 22.51 Buy
200-day EMA: 21.08 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.4 Buy
20-day SMA: 24.33 Buy
50-day SMA: 15.25 Buy
200-day SMA: 15.91 Buy
8-day EMA: 29.74 Buy
20-day EMA: 24.86 Buy
50-day EMA: 18.75 Buy
200-day EMA: 16.3 Buy

NBI Global Real Assets Income ETF Earnings Growth & NREA.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

NBI Global Real Assets Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):